SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
批准号:
3939550
负责人:
E SAUSVILLE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
antibody specificity cell cell interaction cell growth regulation cell membrane cellular oncology crosslink drug design /synthesis /production gastrins guanosine diphosphate human tissue molecular oncology neoplasm /cancer therapy neoplastic cell oncoproteins peptide hormone pituitary gland small cell lung cancer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Previous studies with small cell lung cancer (SCLC) cell lines
have demonstrated that gastrin-releasing peptide (GRP), the
mammalian counterpart to bombesin, is expressed in a
significant fraction of SCLC lines. To assess its role in causing
autocrine stimulation, initial experiments attempted to
demonstrate specific binding to SCLC membrane fractions, with
little success. Accordingly, efforts to define rapid physiologic
responses to GRP were undertaken. These studies demonstrated
clearly that in 5/11 SCLC cell lines tested there was evidence of
calcium mobilization following GRP or bombesin stimulation.
The structure-activity relationship of this effect was in accord
with that expected for GRP receptors in gut, brain, and anterior
pituitary cells. Further studies focused on the relationship of
this response to inositol phosphate metabolism. In a SCLC cell
line with a brisk response to GRP with increased intracellular
calcium, there was evidence of increased inositol 1,4,5
trisphosphate within seconds of addition of bombesin congeners.
Both the mobilization of calcium and inositol phosphate turnover
were inhibited by cholera toxin and active phorbol esters. In the
presence of pertussis toxin there was also a less complete
stimulation of inositol phosphate turnover. In corollary studies it
was demonstrated that the cell lines with the best response to
bombesin showed constitutive expression of L-myc and prepro
GRP without expression of c- or N-myc. In contrast, cell lines
without evidence of response to bombesin had constitutive N- or
C-myc expression.
These studies suggest that an order of progressively malignant
and distinct phenotypes can be defined in SCLC cell lines. A
most "differentiated" cell line would be those which produce and
respond to GRP, and also produce L-myc. A less differentiated
cell line would neither produce nor respond to GRP and express
abundant c- or N-myc. GRP (+), L-myc (+), c-myc (-), and N-
myc (-) cell lines would represent those in which an effort to
block a potential autocrine loop involving GRP might be most
successful.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3916617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS
-
批准号:5201307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3838151
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:3752418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3752419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3774670
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES
-
批准号:2464490
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3774671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3752421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3853203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3838150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:5201344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:5201345
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3752420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3774668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3838148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS--TARGETED THERAPY OF LYMPHOID NEOPLASMS
-
批准号:6123682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
LINEAGE-SPECIFIC MARKER AND PROTO-ONCOGENE EXPRESSION IN HUMAN LUNG CANCER
-
批准号:3939551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3774669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3963280
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
海外基金